---
figid: PMC10311254__fonc-13-1204829-g001
pmcid: PMC10311254
image_filename: fonc-13-1204829-g001.jpg
figure_link: /pmc/articles/PMC10311254/figure/f1/
number: FigureÂ 1
figure_title: ''
caption: MAPK/ERK (green) and PI3K/AKT/mTOR (orange) signaling pathway. In red show
  the inhibitors and the alterations in gene that are causative to dysregulation of
  these pathways in pLGGs.
article_title: 'Unlocking the power of precision medicine for pediatric low-grade
  gliomas: molecular characterization for targeted therapies with enhanced safety
  and efficacy.'
citation: Selene Cipri, et al. Front Oncol. 2023;13:1204829.
year: '2023'

doi: 10.3389/fonc.2023.1204829
journal_title: Frontiers in Oncology
journal_nlm_ta: Front Oncol
publisher_name: Frontiers Media S.A.

keywords:
- pediatric low-grade glioma
- brain tumors
- neuro-oncology
- molecular diagnostic
- clinical trials
- targeted therapies
- risk stratification
- glioma

---
